Position in VCEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,806,261
+$2,136,295 QoQ
Shares Held
197,938
-4.5% QoQ
Ownership
0.387%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. VCEL ranks #67 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in VCEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,806,261 | 197,938 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,669,966 | 207,335 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,941,858 | 248,316 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,995,298 | 254,061 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $15,533,047 | 365,054 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,850,451 | 355,232 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $17,522,824 | 319,119 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $18,726,931 | 443,241 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $23,536,300 | 512,997 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $31,756,908 | 610,475 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $24,044,655 | 675,222 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $23,933,747 | 714,014 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $27,113,064 | 721,668 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $20,720,207 | 706,692 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $17,782,263 | 675,105 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $22,583,690 | 973,435 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $34,351,662 | 1,364,244 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $51,171,342 | 1,338,863 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $50,271,341 | 1,279,169 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $42,592,590 | 872,799 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $33,217,065 | 632,706 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $35,418,013 | 637,588 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $15,252,867 | 493,940 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $8,805,492 | 475,202 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,956,886 | 286,316 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,035,886 | 222,016 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||